Results 171 to 180 of about 9,917,709 (290)
Current Pharmacological Aspects of Treating Lung Cancers
Lung cancer is the leading cause of mortality. As life expectancy is prolonged, morbidity of lung cancer is increased. As of 2023, various mechanisms of molecularly-targeted drugs are available in the market.
Yamazaki, Yuriko
core
Arthritis Care &Research, EarlyView.Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio +28 more
wiley +1 more source
Survival Outcomes in Older Adults with Axial Spondyloarthritis and Concomitant Cancer
Arthritis Care &Research, Accepted Article.Objective The objective of this study was to determine survival outcomes in older adults with axial spondyloarthritis (axSpA) and concomitant cancer. Methods We conducted a population‐based study using Medicare claims data linked to Surveillance, Epidemiology, and End Results data to determine overall survival (OS) and cancer‐specific survival (CSS) in
Savannah Bowman +7 more
wiley +1 more source
Lung Cancers Associated with Cystic Airspaces
Lung cancer, the second most common malignancy in both men and women, poses a significant health burden. Early diagnosis remains pivotal in reducing lung cancer mortality.
Francesco Petrella +15 more
core +1 more source
Advanced Engineering Materials, EarlyView.Sustainability assessment requires methodologies that appropriately distinguish between additive and non‐additive material properties. A toxicity‐weighted scoring system is developed and applied that accounts for the disproportionate influence of highly toxic constituents through nonlinear weighting functions, providing more realistic estimates than ...
Seth Mehalic +2 more
wiley +1 more source
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors. [PDF]
Sci Rep, 2021 Izumi M +15 more
europepmc +1 more source
Multiple primary cancers involving the lung.
Canadian journal of surgery. Journal canadien de chirurgie, 1979 Of 150 consecutive patients with resectable bronchogenic carcinoma, 11 were found to have multiple primary tumours of the respiratory tract. Five patients had more than one primary tumour of the lung and six had previously received treatment for carcinoma of the larynx.
openaire +1 more source
New method for discrimination of multiple primary lung cancer and metastatic lung cancer
Thoracic Cancer, 2022 Cheng Shen, Yong Yuan, Guowei Che
openaire +3 more sources
Fusogenic RNA Nanomodules for Fusion‐Mediated and Multiplexed siRNA Delivery
Advanced Functional Materials, EarlyView.A fusogenic lipid‐layered RNA nanomodules (L‐CRAMs) enable high‐capacity and long‐lasting siRNA delivery through membrane fusion. These nanomodules carry exceptionally large siRNA payloads, avoid conventional endosomal uptake, and release multiple functional siRNAs through Dicer‐mediated processing.
Sunghyun Moon +5 more
wiley +1 more source
Synchronous double primary lung cancers via p53 pathway induced by heavy smoking
Annals of Saudi Medicine, 2010 Differences in the histological manifestation of synchronous lung cancers are rare. Synchronous multiple primary lung cancers (SMPLC) are associated with long-term tobacco use, which could independently lead to mutations in the p53 and K-ras genes.
Lin Cheng-Chih +3 more
doaj